Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2026-01-24 @ 8:27 PM
Study NCT ID:
NCT04642950
Status:
COMPLETED
Last Update Posted:
2024-07-19
First Post:
2020-11-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II/III Study of Sargramostim
Sponsor:
Nobelpharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NPC-26-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None